Genetics and epigenetics in the neurodegenerative disorders of the central nervous system

Chiara Fenoglio

Research output: Chapter in Book/Report/Conference proceedingChapter


Most of the neurodegenerative diseases share several clinical, pathologic, and molecular aspects. Clinically, these diseases are often characterized by an insidious onset during adulthood, after which they progress at different rates, ultimately leading to severe physical disability or death. The symptoms are often common among the different disorders: dementia is not only peculiar of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), but could occur also in Parkinson’s disease (PD) or amyotrophic lateral sclerosis (ALS). Furthermore, under a genetic point of view, many neurodegenerative diseases manifest an important family history, highlighting a relevant contribution of genetic factors to disease causation and progression. Genetics and epigenetics, together with their new designed technologies capable of analyzing genetic variability, have disclosed an appealing scenario that will offer the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex, and rare diseases. In this chapter, an overview of the current genetic and epigenetic progresses in AD, FTD, PD, and ALS, reached by the application of the new genetic technologies, will be provided.

Original languageEnglish
Title of host publicationNeurodegeneratIve Diseases
Subtitle of host publicationClinical Aspects, Molecular Genetics and Biomarkers
PublisherSpringer International Publishing AG
Number of pages20
ISBN (Electronic)9783319729381
ISBN (Print)9783319729374
Publication statusPublished - Jan 1 2018


  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis
  • Epigenetics
  • Frontotemporal dementia
  • Genetics
  • Parkinson’s disease

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Genetics and epigenetics in the neurodegenerative disorders of the central nervous system'. Together they form a unique fingerprint.

Cite this